1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. MEDICAL CANNABIS MARKET BY TYPE
5.1. Introduction
5.2. Indica
5.3. Sativa
6. MEDICAL CANNABIS MARKET BY APPLICATION
6.1. Introduction
6.2. Epilepsy & Seizures
6.3. Posttraumatic Stress Disorder
6.4. Alzheimer’s Disease
6.5. Glaucoma
6.6. Others
7. MEDICAL CANNABIS MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical Companies
7.3. Research Centers
8. MEDICAL CANNABIS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. Americas
8.2.1. By Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Others
8.3. Europe Middle East and Africa
8.3.1. By Type
8.3.2. By Application
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Germany
8.3.4.2. United Kingdom
8.3.4.3. Spain
8.3.4.4. France
8.3.4.5. Others
8.4. Asia Pacific
8.4.1. By Type
8.4.2. By Application
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. China
8.4.4.2. Japan
8.4.4.3. South Korea
8.4.4.4. India
8.4.4.5. Australia
8.4.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Aurora Cannabis Inc.
10.2. Canopy Growth Corporation
10.3. The Cronos Group
10.4. Medical Marijuana, Inc.
10.5. OrganiGram Global
10.6. MediPharm
10.7. AgMedica Bioscience
10.8. Delta 9 Cannabis Inc.
10.9. Glass Pharms
10.10. BOMBAY HEMP COMPANY PVT. LTD. (BOHECO)
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLE